Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | HCAR3 | P49019 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | NNMT | P40261 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 2/20 | 0.34 |
| ▸ | VNN1 | O95497 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL1019109 | 0.82 | MAPK1 (0.40) | MAPK1RAB9AGAAMAPTNPC1 | |
| SCHEMBL14418820 | 0.82 | ALDH1A1 (0.42) | MAPK1RAB9AGAAMAPTNPC1 | |
| SCHEMBL1509187 | 0.81 | MAPK1 (0.41) | MAPK1RAB9ANPC1HCAR3NNMT | |
| Acetone SCHEMBL17732269 | 0.81 | MAPK1 (0.39) | MAPK1RAB9AGAANPC1HCAR3 | |
| SCHEMBL1445644 | 0.80 | MAPK1 (0.40) | MAPK1RAB9AGAAHCAR3NNMT | |
| SCHEMBL30914672 | 0.80 | MAPK1 (0.40) | MAPK1RAB9AGAAHCAR3NNMT | |
| Hydrochloric Acid SCHEMBL5087052 | 0.80 | MAPK1 (0.40) | MAPK1RAB9AHCAR3NNMTGRM5 | |
| SCHEMBL14181985 | 0.80 | NAMPT (0.38) | MAPK1RAB9ANPC1KDM4E | |
| Hydrochloric Acid SCHEMBL310253 | 0.79 | MAPK1 (0.39) | MAPK1RAB9AGAAHCAR3NNMT | |
| Hydrochloric Acid SCHEMBL30019344 | 0.79 | MAPK1 (0.39) | MAPK1RAB9AGAAHCAR3NNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111505264-B | Exosome separation method, immunomagnetic beads and kit | 上海思路迪生物医学科技有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-11747279-B2 | Optical biomodule for detection of diseases at an early onset | MAZED MOHAMMAD A (US) | 2023-09-05 | — | — | US | disclosed |
| US-11747279-B2 | Optical biomodule for detection of diseases at an early onset | MAZED MOHAMMAD A (US) | 2023-09-05 | — | — | US | disclosed |
| US-11320588-B1 | Super system on chip | MAZED MOHAMMAD A (US) | 2022-05-03 | — | — | US | disclosed |
| US-20220003676-A1 | Optical biomodule for detection of diseases at an early onset | MAZED MOHAMMAD A (US) | 2022-01-06 | — | — | US | disclosed |
| US-20210325376-A1 | POLYMERS AND CONJUGATES COMPRISING THE SAME | VENTANA MED SYST INC (US) | 2021-10-21 | — | — | US | disclosed |
| US-11079372-B2 | Polymers and conjugates comprising the same | VENTANA MEDICAL SYSTEMS, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| CN-106432504-B | E-Cadherin, Cadherin-11 and EpCAM multiple antibody immunomagnetic beads and preparation method thereof | 上海美吉生物医药科技有限公司 | 2021-03-30 | — | — | CN | disclosed |
| CN-106279420-B | CD20 antibody immunomagnetic beads and preparation method thereof | 上海美吉生物医药科技有限公司 | 2021-03-30 | — | — | CN | disclosed |
| CN-106279422-B | HER2 antibody immunomagnetic bead and preparation method thereof | 上海美吉生物医药科技有限公司 | 2021-03-30 | — | — | CN | disclosed |
| WO-2013178236-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2013-12-05 | — | — | WO | disclosed |
| WO-2013139803-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2013-09-26 | — | — | WO | disclosed |
| US-20130052731-A1 | HUMANIZED LEWIS-Y SPECIFIC ANTIBODY-BASED DELIVERY OF DICER SUBSTRATE siRNA (D-siRNA) AGAINST STAT3 | MA YUELOG (US) | 2013-02-28 | — | — | US | disclosed |
| US-20120121641-A1 | MHC OLIGOMER AND METHOD OF MAKING THE SAME | PROIMMUNE LIMITED (GB) | 2012-05-17 | — | — | US | disclosed |
| EP-1844072-B1 | MHC OLIGOMER AND METHOD OF MAKING THE SAME | PROIMMUNE LTD (GB) | 2012-04-04 | — | — | EP | disclosed |
| US-20100292183-A1 | TETRACYCLINE AND USES THEREOF | PLAXGEN, INC. | 2010-11-18 | — | — | US | disclosed |
| US-20100292183-A1 | TETRACYCLINE AND USES THEREOF | PLAXGEN, INC. | 2010-11-18 | — | — | US | disclosed |
| US-20080207485-A1 | Mhc Oligomer And Method Of Making The Same | PROIMMUNE LIMITED | 2008-08-28 | — | — | US | disclosed |
| EP-1844072-A1 | MHC OLIGOMER AND METHOD OF MAKING THE SAME | ProImmune Limited (GB) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006082387-A1 | MHC OLIGOMER AND METHOD OF MAKING THE SAME | PROIMMUNE LIMITED (GB) | 2006-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120121641-A1 | MHC OLIGOMER AND METHOD OF MAKING THE SAME | MICA, HLA-DRB1, CD74 | MAPK1 4678/4885RAB9A 3867/4885GAA 2390/4885 |
| US-20130052731-A1 | HUMANIZED LEWIS-Y SPECIFIC ANTIBODY-BASED DELIVERY OF DICER SUBSTRATE siRNA (D-siRNA) AGAINST STAT3 | AGO2, HNRNPH3, HCLS1 | MAPK1 3537/4885RAB9A 62/4885GAA 3215/4885 |
| US-20080207485-A1 | Mhc Oligomer And Method Of Making The Same | MICA, HLA-DRB1, CD74 | MAPK1 4665/4885RAB9A 3784/4885GAA 2362/4885 |
| US-20100292183-A1 | TETRACYCLINE AND USES THEREOF | TET1, TET3, TNNT2 | MAPK1 4509/4885RAB9A 3330/4885GAA 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.